← Back to Search

Survivor Distress for Cancer (AYAST Trial)

N/A
Waitlist Available
Led By Amelia Baffa, RN, MSN
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 15 months after initial visit
Awards & highlights

AYAST Trial Summary

This study is evaluating whether a simple tool can help identify young adult cancer survivors who may need additional mental health support.

AYAST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 15 months after initial visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 15 months after initial visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fetal Distress

AYAST Trial Design

1Treatment groups
Experimental Treatment
Group I: Survivor DistressExperimental Treatment2 Interventions
This intervention will use the NCCN Distress Screening Thermometer to score each participant on their level of distress. Depending on the score the intervention will be tailored to the participant based on the Overview of Evaluation and Treatment Schema DIS-4 per the NCCN Distress Guidelines V1.0, 2016.

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
452 Previous Clinical Trials
31,908 Total Patients Enrolled
Amelia Baffa, RN, MSNPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025